MAPK3 and lung carcinoma: The results demonstrate that solamargine has a potent effect in inhibiting the expression of the DNMT1 protein and the proliferation of human lung cancer cells by decreasing the expression of the prostaglandin E2 (PGE2) receptor protein EP4 and activating ERK1/2 signaling.